Moderate alcohol consumption does not usually interfere with the effectiveness of Malegra, but excessive drinking can increase the risk of low blood pressure and may reduce erectile response. It is safest to limit intake and avoid binge drinking when you plan to use the medication.
The therapeutic window typically spans 4 to 6 hours after ingestion, during which an erection can be achieved with sexual stimulation. The exact duration varies among individuals based on metabolism, age, and concurrent health conditions.
Seek emergency medical care immediately. A prolonged erection (priapism) can cause permanent tissue damage if not treated promptly.
Malegra tablets are usually round, white, and imprinted with the brand name and dosage strength (e.g., “Malegra 100 mg”). Inactive ingredients and tablet shape may differ from other manufacturers, but the active component is the same.
Yes. Malegra is a prescription-only medication (POM) regulated by the MHRA. It must be obtained after a qualified clinician evaluates your suitability.
Patients with controlled hypertension can generally use sildenafil safely, but those with unstable or severe high blood pressure should discuss potential risks with their doctor. Blood-pressure medication may need adjustment.
Sildenafil does not alter sperm production or testosterone concentrations. It works locally in the penile tissue and has no known impact on overall fertility.
Keep the tablets in their original sealed container, away from heat, moisture, and direct sunlight. If you travel by air, place them in your carry-on luggage to avoid temperature extremes in the cargo hold.
Yes. The active ingredient, sildenafil, is available as a generic tablet in the same 100 mg strength. Generic products contain the same amount of active drug and are subject to the same regulatory standards.
Malegra is a prescription-only pill used to treat erectile dysfunction (ED) in adult men. It contains the active ingredient sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor that belongs to the ED medication class. In the United Kingdom, Malegra is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is supplied as a 100 mg tablet. The brand name is used in several markets, but the underlying pharmacology is identical to other sildenafil products.
Sildenafil inhibits the enzyme phosphodiesterase type 5, which normally breaks down cyclic guanosine monophosphate (cGMP) in the penile tissue. By blocking PDE5, the drug allows cGMP to accumulate, leading to smooth-muscle relaxation in the corpus cavernosum. This relaxation permits increased blood flow when sexual stimulation triggers the release of nitric oxide. The result is an erection sufficient for sexual activity. Effects typically begin within 30 minutes, peak at about 1 hour, and may last up to 4-6 hours.
Malegra is MHRA-approved for the treatment of erectile dysfunction in men aged 18 years and older. The medication is taken only when sexual activity is anticipated; it does not cure ED or increase sexual desire. Clinical trials have shown that sildenafil improves the ability to achieve and maintain an erection compared with placebo in men with vascular-related ED. The drug is indicated for use in patients who have a clear physiological cause for erectile difficulty, such as diabetes-related vascular disease, post-prostate-surgery changes, or age-related decline.
Pulmonary arterial hypertension (PAH) - Sildenafil is approved for PAH under the brand name Revatio, but Malegra is not licensed for this indication. Small-scale studies have demonstrated that sildenafil can reduce pulmonary arterial pressure, yet using Malegra for PAH would be off-label and should only occur under specialist supervision.
Altitude-related hypoxia - Preliminary research suggests that sildenafil may improve exercise capacity at high altitude by enhancing oxygen delivery. This application remains investigational and is not endorsed by regulatory agencies.
Disclaimer: Off-label use of Malegra requires careful medical assessment, monitoring for adverse effects, and a clear risk-benefit analysis.
This article provides educational information about Malegra and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
